Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Genesis Therapeutics is a pioneering biotechnology company applying artificial intelligence (AI) and machine learning to revolutionize drug discovery. They focus on developing novel therapies for diseases with high unmet medical needs, particularly those that have been difficult to address with traditional drug development approaches. By integrating advanced AI models with cutting-edge biological research, Genesis Therapeutics aims to accelerate the identification, optimization, and development of promising drug candidates.
Serves as the central hub for research, development, and administrative operations.
Located in a state-of-the-art facility with advanced laboratories and computational resources.
Promotes a collaborative and innovative environment, emphasizing scientific rigor and data-driven decision-making.
The headquarters location allows Genesis Therapeutics to leverage the talent pool and resources available in the San Francisco Bay Area biotech ecosystem.
While headquartered in the US, Genesis Therapeutics's global presence is primarily reflected through partnerships, collaborations, and publications. They engage with researchers and institutions worldwide to advance their drug discovery efforts. They currently only operate in the USA.
201 Haskins Way
South San Francisco
CA
USA
Address: Address unavailable
Expanding research capacity and accessing talent in the San Diego biotech cluster.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Genesis Therapeutics' leadership includes:
Genesis Therapeutics has been backed by several prominent investors over the years, including:
Genesis Therapeutics has experienced some turnover and growth in its executive team in the past year, reflecting the dynamic nature of a rapidly growing biotech company. There have been both new hires and some departures in key leadership positions.
Discover the tools Genesis Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
The most common email format at Genesis Therapeutics appears to be first initial last name.
[first_initial][last]@genesistherapeutics.com
Format
jdoe@genesistherapeutics.com
Example
80%
Success rate
prnewswire.com • 2024-01-18
Genesis Therapeutics will collaborate with Genentech, to accelerate the development of therapeutics for major diseases....more
genesistherapeutics.com • 2023-10-05
Genesis Therapeutics today announced that Tom Gallop, Chief Business Officer, will be departing from the company....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Genesis Therapeutics, are just a search away.